3 tactics to break the stigma of substance use conditions at work. By Suzette Glasner Substance use conditions can be detrimental to a person’s personal and professional life. Because of the stigma associated with substance use, struggling people aren’t given many opportunities to succeed—especially in the workplace. Employees’ fears of[Read More…]
Tag: addiction
HEAL to Host the Inaugural Addiction Recovery Celebration in Whitesburg on July 27th
WHO/WHAT: On July 27th, Help End Addiction for Life, (HEAL), in partnership with Mountain Comprehensive Health Corporation, Addiction Recovery Care, Appalachian Regional Healthcare, and over 40 other local, regional and state organizations, government entities and individuals will host a celebration for addiction recovery called, “Recovery Central”. The event will include a[Read More…]
ARC to begin transitioning clients into new facility Saturday
By Freddie Bourne | Messenger-Inquirer The new rehabilitation facility by Addiction Recovery Care (ARC) at the former OYO Townhouse hotel off West Second Street will begin a partial opening this weekend. The facility — named the Yellow Banks Recovery Center — will be ARC’s first residential treatment program in western[Read More…]
UW researcher says there’s a simple way to help people addicted to fentanyl
By Eilis O’Neill The death toll of the opioid crisis is rising faster in Washington state than anywhere else in the country. Addiction researchers say one thing that could help would be revisiting federal prescribing guidelines for buprenorphine, one of the main medications that can help people addicted to fentanyl or other[Read More…]
Monthly Buprenorphine Initiation Rates Remain Flat, Despite Policy Changes
Jul 19, 2023 Killian Meara Only 1 in 5 patients who initiated buprenorphine were retained in therapy for at least 180 days. Despite several policy changes that aimed to increase access to buprenorphine during the COVID-19 pandemic, monthly initiation rates of buprenorphine therapy have remained flat, according to research results.1[Read More…]
Drop in homicide reports, drug offenses among KSP updates in annual crime report
TOM LATEK | Kentucky Today Jul 19, 2023 FRANKFORT, Ky. (KT) – According to the Kentucky State Police (KSP) annual statewide crime report, overall serious crime rates dropped in 2022 from the prior year, and included fewer reports and arrests for homicides, drug offenses and robberies. The 2022 Crime in[Read More…]
Advocates of using psychedelic drug ibogaine to treat addiction say its risks to the heart can be mitigated in a controlled study
TUESDAY, JULY 18, 2023 By Melissa PatrickKentucky Health News The Kentucky Opioid Abatement Advisory Commission held its first public hearing Monday, July 17, to discuss funding development of an opioid-use disorder treatment using the psychedelic drug ibogaine with some of the money the state is getting from settlements with drug makers and[Read More…]
Mountain State Spotlight explains: West Virginia’s opioid settlement foundation will soon have board members. Here’s how they’re picked.
By Allen Siegler for Mountain State Spotlight Local governments have been selecting their representatives for the West Virginia First Foundation. Here’s the process and what impact they’ll have on the state’s efforts to abate the opioid crisis. In the coming days, local government leaders across West Virginia are set to[Read More…]
Kentucky opioid commission considers proposal on $42M funding for Ibogaine research
BY KHYATI PATEL | KENTUCKY LOUISVILLE, Ky. — The Kentucky Opioid Abatement Advisory Commission is considering a proposal to distribute $42 million. On Monday, the commission heard from experts on a treatment drug called Ibogaine. What You Need To Know Kentucky Opioid Abatement Advisory Commission met to hear about Ibogaine researchAngela Parkerson shared[Read More…]
KY commission hears from experts on promise of psychedelic to treat opioid addiction
ALEX ACQUISTO, TAYLOR SIX Karen Butcher, whose son died in 2020 of an opioid overdose, asked a panel of experts on Monday in Frankfort: If cost wasn’t a factor, why shouldn’t Kentucky explore the use of an illicit psychedelic drug as a treatment for opioid addiction? “If money wasn’t an[Read More…]